avitriptan (BMS-180048)
/ BMS
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 23, 2020
Antimigraine Drug Avitriptan Is a Ligand and Agonist of Human Aryl Hydrocarbon Receptor That Induces CYP1A1 in Hepatic and Intestinal Cells.
(PubMed, Int J Mol Sci)
- "Activation of AhR in reporter gene assays was observed for Avitriptan and to a lesser extent for Donitriptan, while other triptans were very weak or no activators of AhR. Collectively, we show that Avitriptan is a weak ligand and activator of human AhR, which induces the expression of CYP1A1 in a cell-type specific manner. Our data warrant the potential off-label therapeutic application of Avitriptan as an AhR-agonist drug."
Journal • CNS Disorders • Colorectal Cancer • Gastrointestinal Cancer • Migraine • Oncology • Solid Tumor • AHR
October 28, 2019
A domino reaction for generating β-aryl aldehydes from alkynes by substrate recognition catalysis.
(PubMed, Nat Commun)
- "Remarkably, molecular recognition of the ligand and the substrate via hydrogen bonding plays a key role in this step. Control experiments indicate that the reaction further proceeds via 1,4-addition of an arene nucleophile to the unsaturated aldehyde intermediate and subsequent decarboxylation."
Journal
1 to 2
Of
2
Go to page
1